Evolus, Inc.
Pharmaceutical company · Newport Beach, California, United States · Nasdaq: EOLS
Evolus, Inc. is a pharmaceutical company headquartered in Newport Beach, California, United States. Its shares trade on Nasdaq under the ticker EOLS. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2020.
Evolus at a glance
What does Evolus do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $40 million sold (2020).
Frequently asked questions about Evolus
Where is Evolus headquartered?
Evolus, Inc. is headquartered in Newport Beach, California, United States.
What does Evolus do?
Evolus, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Evolus a public company?
Yes. Evolus, Inc. trades on Nasdaq under the ticker EOLS.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.